PhaseBio Pharmaceuticals Inc Business Finance Contracts & Agreements
23 Contracts & Agreements
- Equity Distribution Agreements (1 contract)
- Investor Rights Agreements (1)
- Loan Agreements (3)
- Purchase Agreements (1)
- Security Agreements (1)
- Stock Agreements (3)
- Subordination Agreement (1)
- Underwriting Agreements (3)
- Warrant Agreements (9)
- Equity Distribution Agreement, dated November 10, 2021 by and between PhaseBio Pharmaceuticals, Inc. and William Blair & Company, L.L.C (Filed With SEC on November 10, 2021)
- Underwriting Agreement, dated March 17, 2021 (Filed With SEC on March 19, 2021)
- Asset Purchase Agreement, dated January 13, 2020, by and between PhaseBio Pharmaceuticals, Inc., Viamet Pharmaceuticals Holdings, LLC and Selenity Therapeutics (Bermuda), Ltd (Filed With SEC on March 30, 2020)
- Intellectual Property Security Agreement, dated as of March 19, 2020, by and among PhaseBio Pharmaceuticals, Inc. and Silicon Valley Bank and WestRiver Innovation Lending Fund... (Filed With SEC on March 30, 2020)
- Subordination Agreement, dated as of March 19, 2020, by and among Silicon Valley Bank, WestRiver Innovation Lending Fund VIII, L.P. and SFJ Pharmaceuticals X, Ltd (Filed With SEC on March 30, 2020)
- Consent and First Amendment to Loan and Security Agreement, dated as of March 19, 2020, by and among PhaseBio Pharmaceuticals, Inc. and Silicon Valley Bank and WestRiver... (Filed With SEC on March 30, 2020)
- Description of PhaseBio Pharmaceuticals, Inc. Common Stock (Filed With SEC on March 30, 2020)
- Warrant to Purchase Shares of Common Stock, issued by PhaseBio Pharmaceuticals, Inc. to SFJ Pharmaceuticals X, Ltd. on January 9, 2020 (Filed With SEC on March 30, 2020)
- Warrant to Purchase Shares of Common Stock, issued by PhaseBio Pharmaceuticals, Inc. to WestRiver Innovation Lending Fund VIII, L.P. on October 2, 2019 (Filed With SEC on November 14, 2019)
- Warrant to Purchase Shares of Common Stock, issued by PhaseBio Pharmaceuticals, Inc. to Silicon Valley Bank on October 2, 2019 (Filed With SEC on November 14, 2019)
- Warrant to Purchase Shares of Common Stock, issued by PhaseBio Pharmaceuticals, Inc. to Silicon Valley Bank on July 26, 2019 (Filed With SEC on August 14, 2019)
- Warrant to Purchase Shares of Common Stock, issued by PhaseBio Pharmaceuticals, Inc. to WestRiver Innovation Lending Fund VIII, L.P. on July 26, 2019 (Filed With SEC on August 14, 2019)
- Form of Underwriting Agreement (Filed With SEC on April 9, 2019)
- Loan and Security Agreement, dated as of March 25, 2019, by and among PhaseBio Pharmaceuticals, Inc. and Silicon Valley Bank and WestRiver Innovation Lending Fund VIII, L.P (Filed With SEC on March 26, 2019)
- Warrant to Purchase Shares of Common Stock, issued by PhaseBio Pharmaceuticals, Inc. to WestRiver Innovation Lending Fund VIII, L.P. on March 25, 2019 (Filed With SEC on March 26, 2019)
- Warrant to Purchase Shares of Common Stock, issued by PhaseBio Pharmaceuticals, Inc. to Silicon Valley Bank on March 25, 2019 (Filed With SEC on March 26, 2019)
- 2018 Employee Stock Purchase Plan (Filed With SEC on October 5, 2018)
- Form of Underwriting Agreement (Filed With SEC on October 5, 2018)
- Loan and Security Agreement, dated as of October 18, 2017 and as amended to date, by and between the Registrant and Silicon Valley Bank (Filed With SEC on September 21, 2018)
- Amended and Restated 2002 Stock Plan and Form of Option Agreement and Exercise Notice thereunder, as amended to date (Filed With SEC on September 21, 2018)
- Fourth Amended and Restated Investor Rights Agreement by and among the Registrant and certain of its stockholders, dated August 27, 2018 (Filed With SEC on September 21, 2018)
- Warrant to Purchase Shares of Series C-1 Redeemable Convertible Preferred Stock, issued by the Registrant to Silicon Valley Bank on October 18, 2017 (Filed With SEC on September 21, 2018)
- Form of Warrant to Purchase Shares of Series B Redeemable Convertible Preferred Stock, issued by the Registrant on December 22, 2009 (Filed With SEC on September 21, 2018)
